Table 3.
Operational activities and testing capabilities of blood banks in the West Bank (2025)
| Category | Activity | Type of blood bank | p value | Total Yes, n (%) | Total No, n (%) | |
|---|---|---|---|---|---|---|
| Governmental (n = 14) Yes, n | Non-Governmental (n = 14) Yes, n | |||||
| Donor Phlebotomy | Blood unit collection | 13 | 12 | > 0.999 | 25 (89.3) | 3 (10.7) |
| Blood Grouping | Forward grouping | 14 | 14 | NA | 28 (100.0) | 0 (0.0) |
| Reverse grouping | 14 | 11 | 0.222 | 25 (89.3) | 3 (10.7) | |
| D weak (Du) testing | 14 | 13 | 0.222 | 27 (96.4) | 1 (3.6) | |
| Pretransfusion tests designed to ensure blood compatibility | Crossmatch | 14 | 14 | NA | 28 (100.0) | 0 (0.0) |
| DAT/IAT | 14 | 13 | > 0.999 | 27 (96.4) | 1 (3.6) | |
| Antibody screen (recipients) | 8 | 7 | > 0.999 | 15 (53.6) | 13 (46.4) | |
| Antibody screen (donated units) | 0 | 4 | 0.098 | 4 (14.3) | 24 (85.7) | |
| Antibody identification | 5 | 4 | > 0.999 | 9 (32.1) | 19 (67.9) | |
| Antibody titration | 4 | 4 | NA | 8 (28.6) | 20 (71.4) | |
| Phenotyping | 3 | 2 | > 0.999 | 5 (17.9) | 23 (82.1) | |
| 3.Component Preparation | Whole blood | 3 | 2 | > 0.999 | 5 (17.9) | 23 (82.1) |
| PRBCs | 13 | 12 | > 0.999 | 25 (89.3) | 3 (10.7) | |
| FFP | 8 | 10 | 0.695 | 18 (64.3) | 10 (35.7) | |
| Platelets | 8 | 8 | > 0.999 | 16 (57.1) | 12 (42.9) | |
| Cryoprecipitate | 6 | 6 | > 0.999 | 12 (42.9) | 16 (57.1) | |
| 4. Screening for Infectious Disease | Screening for infectious diseases | 12 | 13 | > 0.999 | 25 (89.3) | 3 (10.7) |
| Rapid tests | 4 | 4 | > 0.999 | 8 (28.6) | 20 (71.4) | |
| 5.Special Procedures | Apheresis | 1 | 3 | 0.596 | 4 (14.3) | 24 (85.7) |
NA: No statistics are computed because a variable is a constant in both groups